The India autoinjector market was valued at USD 815.23 Million in 2025 and is expected to grow at a CAGR of 12.30%, reaching USD 2600.62 Million by 2035. The market growth is driven by increasing prevalence of chronic conditions and adoption of self-administered drug delivery devices.
Base Year
Historical Period
Forecast Period
A surge in biologic drugs for autoimmune, allergic, and oncology indications, which often require parenteral administration, is expected to fuel market demand in the coming years.
Increased investment in R&D through public-private partnerships is boosting innovation, which is projected to elevate the India autoinjector market value in the forecast period.
The rising technological advancements and the growing patient preference for self-administration are significant market trends.
Compound Annual Growth Rate
12.3%
Value in USD Million
2026-2035
*this image is indicative*
The market is experiencing significant growth, driven by the increasing prevalence of chronic diseases such as rheumatoid arthritis, asthma, multiple sclerosis, and diabetes. The rising demand for disposable autoinjectors, owing to their convenience and ease of use, is a key market trend. The market for autoinjectors is further supported by government initiatives that aim to provide affordable healthcare to a larger section of the population. Moreover, the growing focus on next-gen autoinjectors is projected to influence the market dynamics in the coming years.
Rising Prevalence of Chronic Diseases to Augment Market Demand
As per a 2023 article published in the Indian Journal of Rheumatology, rheumatoid arthritis (RA) is identified as the most common form of autoimmune inflammatory arthritis, with a prevalence of approximately 0.75% in India. Alongside rheumatoid arthritis, conditions such as asthma, multiple sclerosis, and diabetes are also witnessing a steady rise. These chronic illnesses typically require long-term, consistent treatment, often involving injectable biologic therapies, and thus, significantly impact the market demand.
The market is witnessing trends like regulatory support and rising technological innovations driving autoinjector demand in India.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Route of Administration
Market Breakup by Application
Market Breakup by End User
Segmentation Based on Type to Witness Substantial Growth
Based on the type, the market is segmented into divided into disposable and reusable autoinjectors. Disposable autoinjectors are single-use devices valued for their ease of use, hygiene, and reduced risk of cross-contamination, making them particularly suitable for emergency situations like anaphylaxis. The reusable autoinjector segment holds a high market share in the Indian market as it offers significant cost advantages over time, especially for patients requiring long-term treatment for chronic conditions such as rheumatoid arthritis and diabetes.
Short Description: The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Sun Pharmaceutical Industries Ltd. has made a significant contribution to the autoinjector market, particularly through its innovative move in 2011 when it received USFDA approval for a Sumatriptan AutoInjector. This was for a generic version of Sumatriptan Succinate Injection, 6 mg/0.5 mL, a treatment for acute migraine and cluster headaches. Further, the company is actively exploring this space, particularly through its specialty division focusing on dermatology, ophthalmology, and oncology.
Dr. Reddy’s Laboratories is recognized for bringing biosimilars and complex injectables to the Indian and global markets, and is gradually entering the autoinjector sector. Known for its affordable healthcare solutions, Dr. Reddy’s has developed biosimilars for key biologics used in rheumatoid arthritis, psoriasis, and cancer, which are often suited for autoinjector delivery.
Pfizer India, the local arm of the global pharmaceutical giant Pfizer Inc., has a growing footprint in India’s specialty and biologics market, including significant contributions to the India autoinjector market growth. Leveraging its global portfolio, Pfizer has introduced several high-end biologics in India, particularly for oncology, immunology, and rare diseases. As Indian healthcare shifts toward home-based care, Pfizer is likely to introduce more autoinjector-enabled treatments.
Amgen, a global leader in biotechnology, is a key player in the India autoinjector market. Known for its pioneering biologics such as Enbrel (etanercept) and Repatha (evolocumab), Amgen has developed sophisticated autoinjector formats for these therapies in international markets. In India, Amgen operates primarily through strategic partnerships, such as its collaboration with Dr. Reddy’s Laboratories, to expand access to its products.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Sanofi, Mylan N.V., BD, SHL Medical, and Biogen Idec.
Upto 15% Off
USD
$3099 $2789
$1999 $1799
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Route of Administration |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share